Sep. 5 at 11:34 AM
📉
$ABM slipping after Q3 earnings miss. Revenue grew +6.2% to
$2.2B (slightly above est.) but EPS came in at
$0.82 adj. vs.
$0.95 expected — down from
$0.84 last year.
⚡ Cash flow was the bright spot: operating cash flow +120% to
$175M & free cash flow +134% to
$150M. Board approved
$150M buyback, showing some confidence.
👀 Guidance narrowed: FY25 EPS now seen at low end of
$3.65–
$3.80, with margin pressure + higher interest costs weighing.
ABM is restructuring to cut ~
$35M in costs by FY26, leaning on AI + efficiency plays. Still, investors aren’t sold until profitability improves.
Is
$ABM just a cash flow story now — or a turnaround waiting to happen?
